merck-lamotrigine dispersible 100 mg tablet
merck generics rsa (pty) ltd - tablet - see ingredients - each tablet contains lamotrigine 100,0 mg
merck-lamotrigine dispersible 200 mg tablet
merck generics rsa (pty) ltd - tablet - see ingredients - each tablet contains lamotrigine 200,0 mg
merck-salbutamol inhaler
merck generics rsa (pty) ltd - inhaler - see ingredients - each actuation delivers salbutamol sulphate equivalent to salbutamol 100,0 ug
merck-gentamycin sulphate 80 (solution for injection)
merck generics rsa (pty) ltd - genatamycin sulphate - injection - gentamycin sulphate equiv. to gentamycin injection 80mg/ 2ml
merck-simvastatin 10mg
merck generics rsa (pty) ltd - simvastatin - tablet - each tablet contains simvastatin 10,0 mg
merck-simvastatin 20mg
merck generics rsa (pty) ltd - simvastatin - tablet - each tablet contains simvastatin 20,0 mg
merck-simvastatin 40mg
merck generics rsa (pty) ltd - simvastatin - tablet - each tablet contains simvastatin 40,0 mg
zostavax
merck sharp & dohme (new zealand) limited - varicella-zoster virus, oka/merck strain, live, attenuated 19400 pfu; - injection with diluent - 19400 pfu - active: varicella-zoster virus, oka/merck strain, live, attenuated 19400 pfu excipient: dibasic sodium phosphate monohydrate gelatin monobasic potassium phosphate monosodium glutamate potassium chloride sodium chloride sucrose urea water for injection - zostavax is indicated for: · prevention of herpes zoster (shingles)
emend 80 mg capsules
merck sharp & dohme israel ltd - aprepitant - capsules - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
emend 80 mg capsules
merck sharp & dohme israel ltd - aprepitant - capsules - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.